{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:36:23Z","timestamp":1769207783708,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T00:00:00Z","timestamp":1631318400000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.semarthrit.2020.05.020","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T11:41:05Z","timestamp":1592307665000},"page":"1109-1113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series"],"prefix":"10.1016","volume":"50","author":[{"given":"Herv\u00e9","family":"Lobbes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Dervout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Toussirot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renaud","family":"Felten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Sibilia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Wendling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Gombert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Ruivard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Grobost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Saraux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divi","family":"Cornec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Soubrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.semarthrit.2020.05.020_bib0001","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/leu.2016.68","article-title":"Population-based analyses among 184 patients diagnosed with large granular lymphocyte leukemia in the Netherlands between 2001 and 2013","volume":"30","author":"Dinmohamed","year":"2016","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.05.020_bib0002","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","article-title":"LGL leukemia: from pathogenesis to treatment","volume":"129","author":"Lamy","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.05.020_bib0003","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0002-9343(89)90300-8","article-title":"Prevalence of granular lymphocyte proliferation in patients with rheumatoid arthritis and neutropenia","volume":"86","author":"Saway","year":"1989","journal-title":"Am J Med"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.05.020_bib0004","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2010-07-296962","article-title":"How I treat LGL leukemia","volume":"117","author":"Lamy","year":"2011","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.05.020_bib0005","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.3899\/jrheum.150051","article-title":"Longterm safety of rituximab: final report of the rheumatoid arthritis global clinical trial program over 11 years","volume":"42","author":"van Vollenhoven","year":"2015","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.05.020_bib0006","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/ard.2010.148759","article-title":"Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries","volume":"70","author":"Chatzidionysiou","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.05.020_bib0007","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1182\/blood-2013-03-491464","article-title":"Long-term remission of T-cell large granular lymphocyte leukemia associated with rheumatoid arthritis after rituximab therapy","volume":"122","author":"Cornec","year":"2013","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.05.020_bib0008","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jbspin.2014.12.001","article-title":"Treatment of pseudo Felty's syndrome: is there a place for rituximab?","volume":"82","author":"Verhoeven","year":"2015","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1016\/j.semarthrit.2020.05.020_bib0009","first-page":"384","article-title":"Rheumatoid arthritis and associated large granular lymphocytic leukemia\u2013successful treatment with rituximab","volume":"40","author":"Raposo","year":"2015","journal-title":"Acta Reumatol Port"},{"key":"10.1016\/j.semarthrit.2020.05.020_bib0010","article-title":"Large granular lymphocytic leukemia: a report of response to rituximab","volume":"2017","author":"Ibrahim","year":"2017","journal-title":"Case Rep Hematol"},{"issue":"9746","key":"10.1016\/j.semarthrit.2020.05.020_bib0011","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.05.020_bib0012","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1182\/blood-2013-03-491464","article-title":"Long-term remission of T-cell large granular lymphocyte leukemia associated with rheumatoid arthritis after rituximab therapy","volume":"122","author":"Cornec","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.05.020_bib0013","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.1038\/bcj.2016.59","article-title":"A population-based study of large granular lymphocyte leukemia","volume":"6","author":"Shah","year":"2016","journal-title":"Blood Cancer J"},{"issue":"13","key":"10.1016\/j.semarthrit.2020.05.020_bib0014","first-page":"5137","volume":"61","author":"Alas","year":"2001","journal-title":"Cancer Res"},{"issue":"16","key":"10.1016\/j.semarthrit.2020.05.020_bib0015","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1182\/blood-2011-02-338517","article-title":"Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia","volume":"118","author":"Clemente","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2020.05.020_bib0016","doi-asserted-by":"crossref","DOI":"10.1111\/imr.12859","article-title":"The role of B cell antigen presentation in the initiation of CD4+ T cell response","author":"Hua","year":"2020","journal-title":"Immunol Rev"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.05.020_bib0017","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13075-016-1152-5","article-title":"Repeated decrease of CD4+ T-cell counts in patients with rheumatoid arthritis over multiple cycles of rituximab treatment","volume":"18","author":"Lavielle","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.05.020_bib0018","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1002\/art.24998","article-title":"Depletion of functionally active CD20+ T cells by rituximab treatment","volume":"60","author":"Wilk","year":"2009","journal-title":"Arthritis Rheumatism"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.05.020_bib0019","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.blre.2013.07.002","article-title":"Anti-CD20 monoclonal antibodies: beyond B-cells","volume":"27","author":"Avivi","year":"2013","journal-title":"Blood Rev"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.05.020_bib0020","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/annrheumdis-2016-209248","article-title":"Anti-carbamylated protein antibodies: a specific hallmark for rheumatoid arthritis. Comparison to conditions known for enhanced carbamylation; renal failure, smoking and chronic inflammation","volume":"75","author":"Verheul","year":"2016","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:06:49Z","timestamp":1758733609000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220301700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0049017220301700"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.020","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rituximab for rheumatoid arthritis-associated large granular lymphocytic leukemia, a retrospective case series","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.05.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}